Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults
- 1 November 2005
- Vol. 23 (46-47) , 5365-5371
- https://doi.org/10.1016/j.vaccine.2005.06.007
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario AnalysisEmerging Infectious Diseases, 2003
- Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for CanadaValue in Health, 2003
- Economic Costs of Influenza-Related Work AbsenteeismValue in Health, 2003
- Pharmacoeconomics of Influenza Vaccination for Healthy Working AdultsDrugs, 2002
- Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The NetherlandsPharmacoEconomics, 2001
- Pharmacoeconomics of Influenza Vaccination in the ElderlyDrugs & Aging, 2000
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus InfectionsThe Journal of Infectious Diseases, 1999
- Economic Evaluation of Influenza VaccinationPharmacoEconomics, 1999
- Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trialArchives of internal medicine (1960), 1996
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985